CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 47 filers reported holding CONATUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $3,000 | -25.0% | 2,946 | +21.5% | 0.00% | – |
Q4 2018 | $4,000 | -69.2% | 2,425 | +7.4% | 0.00% | -100.0% |
Q3 2018 | $13,000 | -99.7% | 2,257 | +99.7% | 0.00% | – |
Q2 2018 | $4,836,000 | +96620.0% | 1,130 | +22.3% | 0.00% | – |
Q1 2018 | $5,000 | -54.5% | 924 | -61.1% | 0.00% | -100.0% |
Q4 2017 | $11,000 | – | 2,376 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JBF Capital, Inc. | 520,553 | $161,000 | 0.03% |
Kalos Management, Inc. | 43,940 | $13,000 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 1,351,000 | $419,000 | 0.00% |
Quilter Plc | 60,546 | $19,000 | 0.00% |
ALBION FINANCIAL GROUP /UT | 12,000 | $4,000 | 0.00% |
REILLY FINANCIAL ADVISORS, LLC | 22,011 | $7,000 | 0.00% |
MORGAN STANLEY | 1,900 | $1,000 | 0.00% |
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 24,900 | $8,000 | 0.00% |
BlackRock Inc. | 645,611 | $200,000 | 0.00% |
Bank of New York Mellon Corp | 137,500 | $43,000 | 0.00% |